Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Document
Document related concepts
no text concepts found
Transcript
New clinical trial for adolescents and adults with Fragile X Syndrome 14-50 years of age PURPOSE: to study the effectiveness and safety of a new drug that is being developed to improve the symptoms of Fragile X Syndrome Sponsored by Pharmaceuticals Taking place at The Kennedy Krieger Institute, Baltimore, Maryland PI: Michael V. Johnston, MD Kennedy Krieger Institute Co-I: Dejan Budimirovic, MD Director, Fragile X Clinic Kennedy Krieger Institute Approved May 8, 2013 Co-I: Tanjala Gipson, MD Kennedy Krieger Institute This research study is free. You will be given $50 for reimbursement for travel and related expenses for each completed visit. Call 443-923-7619 for more information. Protocol Number: NA_00049393
